Citation Impact
Citing Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review
2019
ESUR prostate MR guidelines 2012
2012 Standout
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
The role of cytoreductive nephrectomy in the era of molecular targeted therapy
2009
Targeted therapies for kidney cancer in urologic practice
2007
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer
2010
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Breast cancer
2016 Standout
Robotic versus Open Partial Nephrectomy: A Systematic Review and Meta-Analysis
2014
XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy
2008
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
2016
Investigations of Urothelial Cells Seeded on Commercially Available Small Intestine Submucosa
2006
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
2012
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy
2014
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
An overview of tissue and whole organ decellularization processes
2011 Standout
The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review
2011
Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy
2008
Intravesical gemcitabine: an update of clinical results
2006
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: A meta-analysis and a systematic review of current evidence from comparative studies
2014
Cancer nanotechnology: opportunities and challenges
2005 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
2010 Standout
Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients
2003
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Increased interleukin-10 serum levels in patients with solid tumours
1996
Essential role of miRNAs in orchestrating the biology of the tumor microenvironment
2016
Bladder cancer
2016 Standout
Immunoregulation by members of the TGFβ superfamily
2016
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Intravesical Pharmacotherapy for Non–Muscle-Invasive Bladder Cancer: A Critical Analysis of Currently Available Drugs, Treatment Schedules, and Long-Term Results
2007
Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?
2004
Prevention of Venous Thromboembolism
2004 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Melatonin, endocrine pancreas and diabetes
2007
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material
2015
Prostate Cancer
2003 StandoutNobel
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients: A Review of 17 Randomized Controlled Trials
2008
Prevention of Venous Thromboembolism
2008 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
2017
Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer
2011
Handling and Pathology Reporting of Specimens with Carcinoma of the Urinary Bladder, Ureter, and Renal Pelvis
2003
Fast Track Program in Patients Undergoing Radical Cystectomy: Results in 362 Consecutive Patients
2009
Renal cell carcinoma
2017 Standout
Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer
2012
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial
2014
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
2016
Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
2016
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016
Mindfulness: Theoretical Foundations and Evidence for its Salutary Effects
2007 Standout
Extracorporeal lithotripsy and combined surgical procedures in the treatment of renoureteral stone disease: Our experience with 2,955 patients
1989
Extracorporeal Shock Wave Lithotripsy for Lower Caliceal Calculi
1998
POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
2004
Chemotherapy for advanced gastric cancer
2017 Standout
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
2017 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article
2013
Pooled Analysis of Clinical Outcomes with Neoadjuvant Cisplatin and Gemcitabine Chemotherapy for Muscle Invasive Bladder Cancer
2012
Cancer treatment and survivorship statistics, 2016
2016 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
A New Concept for Early Recovery after Surgery for Patients Undergoing Radical Cystectomy for Bladder Cancer: Results of a Prospective Randomized Study
2013
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Comprehensive Geriatric Assessment for Older Patients With Cancer
2007
Cancer treatment and survivorship statistics, 2019
2019 Standout
Targeting the TGFβ pathway for cancer therapy
2014
RADICAL CYSTECTOMY IN REGIONALLY ADVANCED BLADDER CANCER
1992
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
2010 Standout
The association of preoperative serum albumin level and A merican S ociety of A nesthesiologists ( ASA ) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer
2013
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Role of MRI in Follow-Up After Focal Therapy for Prostate Carcinoma
2010
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Massimo Maffezzini being referenced
Results and complications with the mini-laparotomic incision in 52 consecutive radical retropubic prostatectomies.
2006
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial
2014
Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus
2007
Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder
2009
Incidence and survival of rare urogenital cancers in Europe
2011
Cystine Lithiasis: Combined Extracorporeal and Litholytic Treatment
2015
Evaluation of complications and results in a contemporary series of 300 consecutive radical retropubic prostatectomies with the anatomic approach at a single institution
2003
Salvage immunotherapy with subcutaneous recombinant interleukin 2 (rIL-2) and alpha-interferon (A-IFN) for stage D3 prostate carcinoma failing second-line hormonal treatment
1996
Bladder cancer
1998
Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch
2012
Reversal of Clinical Resistance to LHRHAnalogue in Metastatic ProstateCancer by the Pineal HormoneMelatonin: Efficacy of LHRH Analogueplus Melatonin in Patients Progressingon LHRH Analogue Alone
1997
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer
2016
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer
2006
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes
2014
The pathologist's role in the detection of rare variants of bladder cancer and analysis of the impact on incidence and type detection
2018
Pre-operative assessment of cancer in the elderly (PACE): A comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery
2006
Postchemotherapy Lymphadenectomy in Patients With Metastatic Urothelial Carcinoma: Long-Term Efficacy and Implications for Trial Design
2014
Bladder cancer
2002
Bladder Cell Culture on Small Intestinal Submucosa as Bioscaffold: Experimental Study on Engineered Urothelial Grafts
2004
Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsy.
2006
[Nephron-sparing surgery. Reproducibility of results, personal cases, and comparison with the international literature].
2002
Phase II study of neoadjuvant sorafenib plus cisplatin and gemcitabine (S-CG) for patients with muscle-invasive transitional cell carcinoma of the bladder (MIBC): Results at the end of first stage (NCT01222676).
2014
O8 Testing CGA components to predict 30 days surgery outcome in elderly cancer patient
2006
Systemic Preoperative Chemotherapy with Cisplatin, Methotrexate and Vinblastine for Locally Advanced Bladder Cancer: Local Tumor Response and Early Followup Results
1991
Immunotherapy of advanced renal cell carcinoma
1996
A Multimodal Perioperative Plan for Radical Cystectomy and Urinary Intestinal Diversion: Effects, Limits and Complications of Early Artificial Nutrition
2006
Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation
2015
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help
2007
Extracorporeal Shock Wave Lithotripsy: First Choice Therapy For Ureteral Stones
1989
Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.
2005
Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.
2007